Anthony Atala to Vascular Endothelial Growth Factor A
This is a "connection" page, showing publications Anthony Atala has written about Vascular Endothelial Growth Factor A.
Connection Strength
1.502
-
Atala A. Re: mTORC1 Drives HIF-1a and VEGF-A Signalling via Multiple Mechanisms Involving 4E-BP1, S6K1 and STAT3. J Urol. 2016 Feb; 195(2):524.
Score: 0.523
-
Min S, Cleveland D, Ko IK, Kim JH, Yang HJ, Atala A, Yoo JJ. Accelerating neovascularization and kidney tissue formation with a 3D vascular scaffold capturing native vascular structure. Acta Biomater. 2021 04 01; 124:233-243.
Score: 0.188
-
Liu G, Sun X, Bian J, Wu R, Guan X, Ouyang B, Huang Y, Xiao H, Luo D, Atala A, Zhang Y, Deng C. Correction of diabetic erectile dysfunction with adipose derived stem cells modified with the vascular endothelial growth factor gene in a rodent diabetic model. PLoS One. 2013; 8(8):e72790.
Score: 0.113
-
Liu G, Wang X, Sun X, Deng C, Atala A, Zhang Y. The effect of urine-derived stem cells expressing VEGF loaded in collagen hydrogels on myogenesis and innervation following after subcutaneous implantation in nude mice. Biomaterials. 2013 Nov; 34(34):8617-29.
Score: 0.112
-
Wu S, Wang Z, Bharadwaj S, Hodges SJ, Atala A, Zhang Y. Implantation of autologous urine derived stem cells expressing vascular endothelial growth factor for potential use in genitourinary reconstruction. J Urol. 2011 Aug; 186(2):640-7.
Score: 0.097
-
Soler R, Vianello A, Füllhase C, Wang Z, Atala A, Soker S, Yoo JJ, Koudywilliam J. Vascular therapy for radiation cystitis. Neurourol Urodyn. 2011 Mar; 30(3):428-34.
Score: 0.092
-
Delo DM, Eberli D, Williams JK, Andersson KE, Atala A, Soker S. Angiogenic gene modification of skeletal muscle cells to compensate for ageing-induced decline in bioengineered functional muscle tissue. BJU Int. 2008 Sep; 102(7):878-84.
Score: 0.078
-
Marcus K, Johnson M, Adam RM, O'Reilly MS, Donovan M, Atala A, Freeman MR, Soker S. Tumor cell-associated neuropilin-1 and vascular endothelial growth factor expression as determinants of tumor growth in neuroblastoma. Neuropathology. 2005 Sep; 25(3):178-87.
Score: 0.065
-
De Coppi P, Delo D, Farrugia L, Udompanyanan K, Yoo JJ, Nomi M, Atala A, Soker S. Angiogenic gene-modified muscle cells for enhancement of tissue formation. Tissue Eng. 2005 Jul-Aug; 11(7-8):1034-44.
Score: 0.064
-
Kim BS, Yoo JJ, Atala A. Peripheral nerve regeneration using acellular nerve grafts. J Biomed Mater Res A. 2004 Feb 01; 68(2):201-9.
Score: 0.058
-
Schuch G, Heymach JV, Nomi M, Machluf M, Force J, Atala A, Eder JP, Folkman J, Soker S. Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. Cancer Res. 2003 Dec 01; 63(23):8345-50.
Score: 0.057
-
Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, Atala A, Mukhopadhyay D, Soker S. Antiangiogenic properties of gold nanoparticles. Clin Cancer Res. 2005 May 01; 11(9):3530-4.
Score: 0.016
-
Schuch G, Machluf M, Bartsch G, Nomi M, Richard H, Atala A, Soker S. In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo. Blood. 2002 Dec 15; 100(13):4622-8.
Score: 0.013
-
Nomi M, Atala A, Coppi PD, Soker S. Principals of neovascularization for tissue engineering. Mol Aspects Med. 2002 Dec; 23(6):463-83.
Score: 0.013
-
Schuch G, Kisker O, Atala A, Soker S. Pancreatic tumor growth is regulated by the balance between positive and negative modulators of angiogenesis. Angiogenesis. 2002; 5(3):181-90.
Score: 0.013